Spectrum Asset Management (California)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.57M | Buy |
18,159
+29
| +0.2% | +$6.24K | 1.27% | 22 |
|
|
2026
Q1 | $3.94M | Buy |
18,130
+45
| +0.2% | +$9.98K | 1.25% | 25 |
|
|
2025
Q4 | $4.13M | Sell |
18,085
-2,472
| -12% | -$563K | 1.38% | 24 |
|
|
2025
Q3 | $4.76M | Sell |
20,557
-53
| -0.3% | -$10.8K | 1.67% | 17 |
|
|
2025
Q2 | $3.83M | Sell |
20,610
-236
| -1% | -$43.9K | 1.66% | 24 |
|
|
2025
Q1 | $4.37M | Sell |
20,846
-26
| -0.1% | -$5.05K | 1.94% | 19 |
|
|
2024
Q4 | $3.71M | Sell |
20,872
-1,197
| -5% | -$220K | 1.67% | 21 |
|
|
2024
Q3 | $4.36M | Sell |
22,069
-101
| -0.5% | -$18.9K | 1.84% | 17 |
|
|
2024
Q2 | $3.8M | Buy |
22,170
+704
| +3% | +$117K | 1.76% | 19 |
|
|
2024
Q1 | $3.91M | Sell |
21,466
-480
| -2% | -$82.7K | 1.68% | 22 |
|
|
2023
Q4 | $3.4M | Sell |
21,946
-649
| -3% | -$94.6K | 1.51% | 24 |
|
|
2023
Q3 | $3.37M | Sell |
22,595
-493
| -2% | -$72.4K | 1.77% | 21 |
|
|
2023
Q2 | $3.11M | Sell |
23,088
-2,395
| -9% | -$351K | 1.55% | 21 |
|
|
2023
Q1 | $4.06M | Sell |
25,483
-238
| -0.9% | -$36.4K | 2.01% | 12 |
|
|
2022
Q4 | $4.16M | Buy |
25,721
+401
| +2% | +$61.5K | 2.02% | 13 |
|
|
2022
Q3 | $3.4M | Buy |
25,320
+1,221
| +5% | +$175K | 1.74% | 13 |
|
|
2022
Q2 | $3.69M | Buy |
24,099
+1
| +0% | +$153 | 1.82% | 10 |
|
|
2022
Q1 | $3.91M | Buy |
24,098
+52
| +0.2% | +$7.55K | 1.53% | 20 |
|
|
2021
Q4 | $3.26M | Sell |
24,046
-3,689
| -13% | -$436K | 0.92% | 29 |
|
|
2021
Q3 | $2.99M | Sell |
27,735
-125
| -0.4% | -$14.3K | 0.92% | 33 |
|
|
2021
Q2 | $3.14M | Sell |
27,860
-1,100
| -4% | -$124K | 0.94% | 36 |
|
|
2021
Q1 | $3.13M | Sell |
28,960
-240
| -0.8% | -$25.7K | 0.97% | 31 |
|
|
2020
Q4 | $3.13M | Sell |
29,200
-1,305
| -4% | -$125K | 1.12% | 23 |
|
|
2020
Q3 | $2.67M | Sell |
30,505
-130
| -0.4% | -$12.2K | 1.12% | 20 |
|
|
2020
Q2 | $3.01M | Sell |
30,635
-2,575
| -8% | -$227K | 1.55% | 15 |
|
|
2020
Q1 | $2.53M | Buy |
33,210
+595
| +2% | +$50.7K | 2.41% | 9 |
|
|
2019
Q4 | $2.89M | Sell |
32,615
-700
| -2% | -$58.1K | 1.59% | 18 |
|
|
2019
Q3 | $2.52M | Buy |
33,315
+23,475
| +239% | +$1.61M | 1.62% | 17 |
|
|
2019
Q2 | $716K | Hold |
9,840
| – | – | 0.45% | 60 |
|
|
2019
Q1 | $793K | Sell |
9,840
-20
| -0.2% | -$1.64K | 0.53% | 58 |
|
|
2018
Q4 | $909K | Sell |
9,860
-4,000
| -29% | -$352K | 0.72% | 49 |
|
|
2018
Q3 | $1.31M | Buy |
+13,860
| New | +$1.31M | 0.78% | 43 |
|
Other funds holding ABBV
Spectrum Asset Management (California)'s ABBV Position: Q2 2026 in Review
Spectrum Asset Management (California) increased its AbbVie (ABBV) stake by 0.16% in Q2 2026, buying an estimated $6.24K and bringing the position to 18,159 shares worth $4.57M. The position accounts for 1.27% of the portfolio, ranked #22.
Spectrum Asset Management (California) first reported a position in ABBV in Q3 2018 and has held it in 32 quarters since. The position peaked at $4.76M in Q3 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Spectrum Asset Management (California) held 18,159 shares of AbbVie worth $4.57M as of Q2 2026.
- Spectrum Asset Management (California) bought 29 AbbVie shares in Q2 2026, an estimated $6.24K.
- AbbVie made up 1.27% of Spectrum Asset Management (California)'s portfolio in Q2 2026, its #22 holding.
- Spectrum Asset Management (California) first reported a position in AbbVie in Q3 2018 and has held it in 32 quarters since.
- Spectrum Asset Management (California)'s AbbVie position peaked at $4.76M in Q3 2025.
- 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Spectrum Asset Management (California)'s 13F filing for Q2 2026, filed 3 Aug 2026.